Peridone
General properties
Agents, used for functional gastrointestinal disorders. Stimulants peristalsis (propulsanty).
- To facilitate the symptoms of nausea and vomiting lasting less than 48 hours.
Increased sensitivity to the drug and / or its components.
Prolactin-secretory pituitary tumor (prolactinoma).
Violations of the liver and / or kidneys.
Known QT interval prolongation, which is the basis of disorders or diseases of the heart.
Formulation should not be used if the stimulation of gastric motility can be unsafe, such as gastrointestinal bleeding, perforation, or mechanical obstruction.
Concomitant use of ketoconazole, erythromycin or other potent CYP3A4 inhibitors, drugs, prolonging the interval the QT, such as fluconazole, erythromycin, itraconazole, oral ketoconazole, posaconazole, ritonavir, saquinavir, telaprevir, voriconazole, clarithromycin, amiodarone, telithromycin (see. Forums "Peculiarities of the application" and "Interaction with other medicinal products and other forms of interaction ").
Pharmaceutical characteristics
Tablets of white or almost white color.
Keep out of reach of children in original package at temperature not exceeding 25 °С.
